top of page
The Professional Network for Healthcare Experts
Roche licenses Rona Therapeutics ALK7-targeting RNAi obesity therapy in deal worth up to $1.16 billion
Roche has secured worldwide rights to Rona Therapeutics' investigational ALK7-targeting RNAi therapy in an obesity and metabolic disease licensing agreement worth up to $1.16 billion.
nuaxia
Oct 152 min read
Zealand Pharma signs AI protein therapeutics collaboration with Generate Biomedicines worth over $1 billion
Zealand Pharma and Generate Biomedicines have signed an AI-enabled protein therapeutics collaboration for obesity and metabolic diseases with potential milestone payments approaching $1.2 billion.
nuaxia
Oct 152 min read
bottom of page